EMRYPKENPriority claimed from 18/05/2023; Application No. : 98002552 ;United States of America (Class 5)
#6171788
Application Number:6171788
Status: Unknown
Class:5
Applicant:GENZYME CORPORATION
Filing Date:Wed, 01 Nov 2023
In Progress
Is this your trademark application?
"EMRYPKENPriority claimed from 18/05/2023; Application No. : 98002552 ;United States of America" is still moving through the registration pipeline. Most applications hit at least one hurdle — objection, opposition or a hearing — and deadlines at each stage are short. Get notified the moment the status changes.
Trademark Information
| Trademark | EMRYPKENPriority claimed from 18/05/2023; Application No. : 98002552 ;United States of America |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 6171788 |
| Nature/Scope of business | Pharmaceutical products for the prevention and treatment of immunological diseases, pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, pharmaceutical preparations for the treatment of Amyotrophic Lateral Sclerosis and Multiple Sclerosis and Alzheimer’s |
| Publication | In Journal No. 2134 |
| Status | Unknown |
| Applicant: | GENZYME CORPORATION |
| Applicant Address | 450 Water Street, CAMBRIDGE, MA 02141, UNITED STATES OF AMERICA A Massachusetts corporation, USA |
| Jurisdiction | DELHI |
| Agent | REMFRY & SAGAR |
| Agent Address | REMFRY HOUSE AT THE MILLENNIUM PLAZA SEC 27, GURGAON 122009, NEW DELHI NATIONAL CAPITAL REGION INDIA |
Frequently Asked Questions
Who is the owner of trademark EMRYPKENPriority claimed from 18/05/2023; Application No. : 98002552 ;United States of America? ▾
The trademark application number 6171788 is owned by GENZYME CORPORATION.
Which class does trademark EMRYPKENPriority claimed from 18/05/2023; Application No. : 98002552 ;United States of America belong to? ▾
Trademark application number 6171788 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 6171788? ▾
The trademark agent associated with application number 6171788 is REMFRY & SAGAR.
Was trademark EMRYPKENPriority claimed from 18/05/2023; Application No. : 98002552 ;United States of America published in the journal? ▾
Yes, trademark application number 6171788 was published in Journal No. 2134.
What is trademark EMRYPKENPriority claimed from 18/05/2023; Application No. : 98002552 ;United States of America? ▾
Trademark application number 6171788 relates to "Pharmaceutical products for the prevention and treatment of immunological diseases, pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, pharmaceutical preparations for the treatment of Amyotrophic Lateral Sclerosis and Multiple Sclerosis and Alzheimer’s".
File Trademark at Just ₹1,499 + Govt Fees
Get your trademark registered with expert guidance. Limited time offer!
File NowExpert Consultation
Quick Processing
100% Support
Free Report
Get Detailed Trademark Report
Comprehensive analysis of your trademark search delivered to your phone
What you'll get:
- Complete trademark analysis
- Conflict assessment
- Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified